Nutrition and recovery after pancreatic cancer surgery
Part of Hormones & metabolism clinical trials.
This study looks at how nutrition before and after surgery affects recovery for people with pancreatic cancer that can be removed. By reviewing medical records of past patients, researchers hope to learn how to better support patients through their treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have pancreatic cancer confirmed by a biopsy
- Your tumor can be removed with surgery (curative treatment)
- You had surgery at the NHC hospital in Strasbourg between January 2018 and December 2022
- You have not said no to having your medical data used for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a home-based exercise and nutrition program can help people with pancreatic cancer get stronger before surgery. It’s designed for those who are not already doing regular strength training.
This trial tests whether a special nutrition program can help people with pancreatic cancer who are getting chemotherapy before surgery. The program includes diet changes, supplements, and exercise support to see if it improves strength, weight, and overall well-being.
This study tests whether a special nutrition plan before and after Whipple surgery (a major operation for pancreatic or bile duct cancer) helps patients recover faster and feel better. Researchers want to see if eating the right nutrients beforehand makes surgery easier on your body.
This trial tests an AI-powered app that helps with nutrition after pancreatic cancer surgery. It aims to improve your recovery by giving personalized dietary guidance.
This trial tests whether a special drink called Peptamen 1.6 can help improve nutrition and recovery in patients who are malnourished or at risk and have had surgery for pancreatic cancer. It aims to understand how the supplement affects the body right after surgery.
This trial studies and analyzes tissue samples from people who had surgery for exocrine pancreatic (pancreatic duct-type) cancer. It may help researchers better understand the disease biology and improve future care.
Hear when a new Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.